Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Marshall, A. T.
Right arrow Articles by Crisp, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, A. T.
Right arrow Articles by Crisp, A. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2000; 39: 692-695
© 2000 British Society for Rheumatology


Editorials

Reflex sympathetic dystrophy

A. T. Marshall and A. J. Crisp1

Department of Rheumatology, Norfolk and Norwich NHS Trust, Brunswick Road, Norwich NR1 3SR,
1 Department of Rheumatology, Addenbrooke's NHS Trust, Hills Road, Cambridge CB2 2QQ, UK

The first 150 words of the full text of this article appear below.

Reflex sympathetic dystrophy (RSD) is a condition characterized by localized or diffuse pain, usually with associated swelling, trophic changes and vasomotor disturbance [1]. Allodynia, hyperhydrosis, and nail or hair growth changes may also occur. Motor abnormalities have been reported [2], in particular, tremor, involuntary movement and muscle spasm. Contractures may occur in the later stages. Involvement may be either unilateral or bilateral. Most commonly recognized is peripheral disease [3], although RSD may affect any region of the trunk or limbs. There is often a history of trauma, occasionally of such low significance that it may be overlooked by the patient. Symptoms may occur up to 6 months after injury [4]. Other triggering factors have been reported. Several drugs have been implicated, for example, phenobarbitone, phenytoin, isoniazid [5], and the immunosuppressive agents cyclosporin [6] and tacrolimus [7], . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Hand Surg Eur VolHome page
A. ZYLUK
Complex Regional Pain Syndrome Type I. Risk Factors, Prevention and Risk of Recurrence
J Hand Surg Eur Vol., August 1, 2004; 29(4): 334 - 337.
[Full Text] [PDF]


Home page
J Hand Surg Eur VolHome page
A. ZYLUK
A New Clinical Severity Scoring System for Reflex Sympathetic Dystrophy of the Upper Limb
J Hand Surg Eur Vol., June 1, 2003; 28(3): 261 - 262.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
L L Smith, S P Burnet, and J D McNeil
Musculoskeletal manifestations of diabetes mellitus
Br. J. Sports Med., February 1, 2003; 37(1): 30 - 35.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. G. Cleary, J. A. Sills, J. E. Davidson, and A. M. Cohen
Reflex sympathetic dystrophy
Rheumatology, May 1, 2001; 40(5): 590 - 591.
[Full Text] [PDF]